Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor class drugs

4 results

  • valcyte

    (valganciclovir)
    H2-Pharma, LLC
    VALCYTE is indicated for the treatment of cytomegalovirus (CMV) retinitis in adults with AIDS and for the prevention of CMV disease in high-risk kidney and heart transplant patients. It is also used in pediatric patients (4 months to 16 years) for preventing CMV disease post-kidney or heart transplant.
    Medication Details
    Drug Interactions

  • valganciclovir

    (Valganciclovir hydrochloride powder,)
    Aurobindo Pharma Limited
    Valganciclovir tablets are indicated for treating Cytomegalovirus (CMV) retinitis in AIDS patients and preventing CMV disease in high-risk kidney, heart, and kidney-pancreas transplant patients. The oral solution is also indicated for preventing CMV disease in pediatric patients (1 month to 16 years) undergoing kidney and heart transplants.
    Medication Details
    Drug Interactions

  • valganciclovir hydrochloride

    (VALGANCICLOVIR)
    Somerset Therapeutics, LLC
    Valganciclovir hydrochloride is indicated for treating cytomegalovirus (CMV) retinitis in AIDS patients and for preventing CMV disease in high-risk kidney, heart, and kidney-pancreas transplant patients. It is also used in pediatric patients aged 1 month to 16 years for CMV disease prevention in transplant scenarios.
    Medication Details
    Drug Interactions

  • valganciclovir hydrochloride

    (VALGANCICLOVIR HYDROCHLORIDE)
    Aurobindo Pharma Limited
    Valganciclovir tablets are indicated for the treatment of cytomegalovirus (CMV) retinitis in AIDS patients and for the prevention of CMV disease in high-risk kidney, heart, and kidney-pancreas transplant patients, as well as in pediatric kidney and heart transplant patients aged 1 month to 16 years.
    Medication Details
    Drug Interactions